Kishen Morarji

Learn More
IMPORTANCE Risk stratification of patients with nonischemic dilated cardiomyopathy is primarily based on left ventricular ejection fraction (LVEF). Superior prognostic factors may improve patient selection for implantable cardioverter-defibrillators (ICDs) and other management decisions. OBJECTIVE To determine whether myocardial fibrosis (detected by late(More)
BACKGROUND Cardiovascular magnetic resonance is the gold-standard technique for the assessment of ventricular function. Although left ventricular volumes and ejection fraction are strong predictors of outcome in dilated cardiomyopathy (DCM), there are limited data regarding the prognostic significance of right ventricular (RV) systolic dysfunction (RVSD).(More)
Ankur Gulati, MD*; Tevfik F. Ismail, MD*†; Andrew Jabbour, MD, PhD*; Francisco Alpendurada, MD*; Kaushik Guha, MD*†; Nizar A. Ismail, BSc*; Sadaf Raza, MD*; Jahanzaib Khwaja, BSc*; Tristan D.H. Brown, BSc*; Kishen Morarji, MD*; Emmanouil Liodakis, MD*; Michael Roughton, MSc*; Ricardo Wage, DCR*; Tapesh C. Pakrashi, MD*; Rakesh Sharma, MD, PhD*†; John-Paul(More)
AIMS Echocardiographic studies have shown that left atrial volume (LAV) predicts adverse outcome in small heart failure (HF) cohorts of mixed aetiology. However, the prognostic value of LAV in non-ischaemic dilated cardiomyopathy (DCM) is unknown. Cardiovascular magnetic resonance (CMR) allows accurate and reproducible measurement of LAV. We sought to(More)
Methods Consecutive patients with DCM referred for CMR between 2002-2008 were prospectively enrolled. The diagnosis of DCM was made using clinical, CMR and coronary angiographic findings. Patients with ischemic heart disease, primary valvar disease and infiltrative CM were excluded. LGE-CMR at 1.5T (Siemens Sonata or Avanto, Germany) was performed in 2(More)
  • 1